-
公开(公告)号:US07189722B2
公开(公告)日:2007-03-13
申请号:US10547227
申请日:2004-03-10
申请人: Ian M. Bell , Cory R. Theberge , Xu-Fang Zhang , C. Blair Zartman
发明人: Ian M. Bell , Cory R. Theberge , Xu-Fang Zhang , C. Blair Zartman
IPC分类号: A61K31/4166 , A61K31/498 , A61K31/4709 , A61K31/427 , C07D233/76 , C07D241/36 , C07D215/14 , C07D277/28
CPC分类号: C07D235/02 , C07D401/12 , C07D403/12 , C07D417/12
摘要: The present invention is directed to compounds that are antagonists of CGRP receptors and that are useful in the treatment or prevention of diseases in which the CGRP is involved, such as headache, migraine and cluster headache. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
摘要翻译: 本发明涉及作为CGRP受体的拮抗剂的化合物,其可用于治疗或预防涉及CGRP的疾病,例如头痛,偏头痛和丛集性头痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及CGRP的疾病中的用途。
-
公开(公告)号:US5939439A
公开(公告)日:1999-08-17
申请号:US995744
申请日:1997-12-22
申请人: Neville J. Anthony , Samuel L. Graham , Lekhanh O. Tran , Ian M. Bell , S. Jane deSolms , Robert P. Gomez , Michelle Sparks Kuo , William C. Lumma, Jr. , Debra S. Perlow , Anthony W. Shaw , John S. Wai , Steven D. Young
发明人: Neville J. Anthony , Samuel L. Graham , Lekhanh O. Tran , Ian M. Bell , S. Jane deSolms , Robert P. Gomez , Michelle Sparks Kuo , William C. Lumma, Jr. , Debra S. Perlow , Anthony W. Shaw , John S. Wai , Steven D. Young
IPC分类号: C07D401/10 , C07D401/12 , C07D401/14 , C07D403/10 , C07D405/14 , C07D417/14 , C07D471/04 , C07D401/04 , A61K31/44
CPC分类号: C07D401/10 , C07D401/12 , C07D401/14 , C07D403/10 , C07D405/14 , C07D417/14 , C07D471/04
摘要: The present invention is directed to compounds which inhibit farnesyl-protein transferase (FTase) and the farnesylation of the oncogene protein Ras. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for inhibiting farnesyl-protein transferase and the farnesylation of the oncogene protein Ras.
-
公开(公告)号:US5756497A
公开(公告)日:1998-05-26
申请号:US807307
申请日:1997-02-27
IPC分类号: C07D413/14 , C07D265/18 , A61K31/535
CPC分类号: C07D413/14
摘要: This invention relates to certain novel benzoxazinone compounds and derivatives thereof, their synthesis, and their use as oxytocin receptor antagonists. One application of these compounds is in the treatment of preterm labor in mammals, especially humans. The ability of the compounds to relax uterine contractions in mammals also makes them useful for treating dysmenorrhea and stopping labor prior to cesarean delivery.
-
公开(公告)号:US5574044A
公开(公告)日:1996-11-12
申请号:US329757
申请日:1994-10-27
申请人: Wayne J. Thompson , Michael F. Sugrue , Richard W. Ransom , Pierre J. Mallorga , Ian M. Bell , Anthony M. Smith
发明人: Wayne J. Thompson , Michael F. Sugrue , Richard W. Ransom , Pierre J. Mallorga , Ian M. Bell , Anthony M. Smith
IPC分类号: C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12 , A61K31/445
CPC分类号: C07D401/04 , C07D401/12 , C07D401/14 , C07D403/12
摘要: Compounds, 1,3-dihydro-1-{1-[piperidin-4-yl]piperidin-4-yl}-2H-benzimidazol-2-ones and 1,3-dihydro-1-{4-amino-1-cyclohexyl}-2H-benzimidazol-2-ones and derivatives thereof, their preparation, method of use and pharmaceutical compositions are described. These compounds are endowed with antimuscarinic activity and are useful in the treatment and/or prevention of myopia (commonly known as nearsightedness).
摘要翻译: 化合物,1,3-二氢-1- {1- [哌啶-4-基]哌啶-4-基} -2H-苯并咪唑-2-酮和1,3-二氢-1- {4-氨基-1- 环己基} -2H-苯并咪唑-2-酮及其衍生物,其制备方法,使用方法和药物组合物。 这些化合物具有抗毒蕈碱活性,可用于治疗和/或预防近视(俗称近视)。
-
公开(公告)号:US20230227441A1
公开(公告)日:2023-07-20
申请号:US18009306
申请日:2021-06-14
申请人: Ashok ARASAPPAN , Ian M. BELL , Christopher James BUNGARD , Christopher S. BURGEY , Jason M. COX , Deodial Guy GUIADEEN , Michael J. KELLY , Mark E. LAYTON , Hong LIU , Jian LIU , James T. OLSEN , James J. PERKINS , Jeffrey W. SCHUBERT , Akshay A. SHAH , Michael D. VANHEYST , Zhe WU , Shawn J. STACHEL , MERCK SHARP & DOHME CORP.
发明人: Ashok Arasappan , Ian M. Bell , Christopher James Bungard , Christopher S. Burgey , Jason Michael Cox , Deodial Guy Guiadeen, III , Michael J. Kelly, III , Mark E. Layton , Hong Liu , Jian Liu , James T. Olsen , James J. Perkins , Jeffrey W. Schubert , Akshay A. Shah , Shawn J. Stachel , Michael David VanHeyst , Zhe Wu
IPC分类号: C07D413/12 , C07D263/24 , C07D417/12
CPC分类号: C07D413/12 , C07D263/24 , C07D417/12
摘要: Novel compounds of the structural formula (I), and the pharmaceutically acceptable salts thereof, are inhibitors of Nav1.8 channel activity and may be useful in the treatment, prevention, management, amelioration, control and suppression of diseases mediated by Nav1.8 channel activity. The compounds of the present invention may be useful in the treatment, prevention or management of pain disorders, cough disorders, acute itch disorders, and chronic itch disorders.
-
公开(公告)号:US08912210B2
公开(公告)日:2014-12-16
申请号:US13293177
申请日:2011-11-10
申请人: Ian M. Bell , Mark E. Fraley , Steven N. Gallicchio , Anthony Ginnetti , Helen J. Mitchell , Daniel V. Paone , Donnette D. Staas , Cheng Wang , C. Blair Zartman
发明人: Ian M. Bell , Mark E. Fraley , Steven N. Gallicchio , Anthony Ginnetti , Helen J. Mitchell , Daniel V. Paone , Donnette D. Staas , Cheng Wang , C. Blair Zartman
IPC分类号: A01N43/42 , A61K31/44 , C07D221/02
CPC分类号: A61K31/4545 , A61K31/435 , A61K31/438 , C07D471/10 , C07D471/20
摘要: The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
-
公开(公告)号:US20140128375A1
公开(公告)日:2014-05-08
申请号:US14152522
申请日:2014-01-10
申请人: Ian M. Bell , Harold B. Selnick
发明人: Ian M. Bell , Harold B. Selnick
IPC分类号: C07D487/04 , C07D471/10 , A61K45/06 , C07D498/20 , C07D471/20 , A61K31/55
CPC分类号: C07D487/04 , A61K31/55 , A61K45/06 , C07D471/10 , C07D471/20 , C07D498/20 , C07D519/00
摘要: Compounds of formula I: (wherein variables A1, m, R1, R2, R3, R4 and Z are as described herein) which are antagonists of CGRP receptors and which are useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
摘要翻译: 式I化合物(其中变量A1,m,R1,R2,R3,R4和Z如本文所述),其是CGRP受体的拮抗剂,其可用于治疗或预防涉及CGRP的疾病, 如偏头痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物用于预防或治疗涉及CGRP的疾病的用途。
-
公开(公告)号:US20130231358A1
公开(公告)日:2013-09-05
申请号:US13884632
申请日:2011-11-10
申请人: Ian M. Bell , Mark E. Fraley , Steven N. Gallicchio , Anthony Ginnetti , Helen J. Mitchell , Daniel V. Paone , Donnette D. Staas , Cheng Wang , Blair C. Zartman , Heather E. Stevenson
发明人: Ian M. Bell , Mark E. Fraley , Steven N. Gallicchio , Anthony Ginnetti , Helen J. Mitchell , Daniel V. Paone , Donnette D. Staas , Cheng Wang , Blair C. Zartman , Heather E. Stevenson
IPC分类号: C07D471/04 , C07D487/04
CPC分类号: C07D471/04 , A61K31/506 , C07D487/04
摘要: The present invention is directed to piperidinone carboxamide indane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
摘要翻译: 本发明涉及作为CGRP受体的拮抗剂的哌啶酮羧酰胺二氢化茚衍生物,其可用于治疗或预防涉及CGRP的疾病,例如偏头痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及CGRP的疾病中的用途。
-
公开(公告)号:US20120122899A1
公开(公告)日:2012-05-17
申请号:US13293166
申请日:2011-11-10
申请人: Ian M. Bell , Mark E. Fraley , Steven N. Gallicchio , Anthony Ginnetti , Helen J. Mitchell , Daniel V. Paone , Donnette D. Staas , Heather E. Stevenson , Cheng Wang , C. Blair Zartman
发明人: Ian M. Bell , Mark E. Fraley , Steven N. Gallicchio , Anthony Ginnetti , Helen J. Mitchell , Daniel V. Paone , Donnette D. Staas , Heather E. Stevenson , Cheng Wang , C. Blair Zartman
IPC分类号: A61K31/439 , A61K31/527 , A61P25/06 , C07D471/20
CPC分类号: A61K31/4545 , A61K31/435 , A61K31/438 , C07D471/10 , C07D471/20
摘要: The present invention is directed to piperidinone carboxamide azaindane derivatives which are antagonists of CGRP receptors and useful in the treatment or prevention of diseases in which the CGRP is involved, such as migraine. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which CGRP is involved.
摘要翻译: 本发明涉及作为CGRP受体的拮抗剂的哌啶酮羧酰胺氮杂茚衍生物,其可用于治疗或预防涉及CGRP的疾病,例如偏头痛。 本发明还涉及包含这些化合物的药物组合物以及这些化合物和组合物在预防或治疗涉及CGRP的疾病中的用途。
-
公开(公告)号:US20120121508A1
公开(公告)日:2012-05-17
申请号:US13386955
申请日:2010-07-20
申请人: Ian M. Bell , Eric Hostetler , Harold G. Selnick , Craig A. Stump
发明人: Ian M. Bell , Eric Hostetler , Harold G. Selnick , Craig A. Stump
IPC分类号: A61K51/04 , A61P25/00 , C07D471/10
CPC分类号: C07D471/10 , C07B59/002 , C07D471/20
摘要: The present invention is directed to radiolabeled CGRP receptor antagonists which are useful for the quantitative imaging of CGRP receptors in mammals.
摘要翻译: 本发明涉及放射性标记的CGRP受体拮抗剂,其可用于哺乳动物中CGRP受体的定量成像。
-
-
-
-
-
-
-
-
-